p57(Kip2), A glucocorticoid-induced inhibitor of cell cycle progression in HeLa cells

Molecular Endocrinology

Volumn 13, Issue 11, 1999, Pages 1811-1822

  Samuelsson, M K R ^a   Pazirandeh, A ^a   Davani, B ^a   Okret, S ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; DEXAMETHASONE; DOXYCYCLINE; GLUCOCORTICOID; MIFEPRISTONE; TETRACYCLINE; CDK2 PROTEIN, HUMAN; CDKN1C PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYCLIN E; HORMONE ANTAGONIST; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE; THYMIDINE;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; GENE OVEREXPRESSION; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; CELL CYCLE; CELL DIVISION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

CDC2-CDC28 KINASES; CELL CYCLE; CELL DIVISION; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P57; CYCLIN-DEPENDENT KINASES; DEXAMETHASONE; DOXYCYCLINE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOCORTICOIDS; HELA CELLS; HORMONE ANTAGONISTS; HUMANS; MIFEPRISTONE; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; THYMIDINE;

EID: 0033237650     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.11.0379     Document Type: Article

References (64)

1. Adrenal disease
2. Steroid hormone receptors: Many actors in search of a plot
3. 1 block in cell cycle progression
4. Glucocorticoid receptor-mediated cell cycle arrest is achieved through cell-specific transcriptional regulatory mechanisms
5. c-Myc and cyclin D3 (CcnD3) Genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation
6. Expression of c-Myc in glucocorticoid-treated fibroblastic cells
7. Involvement of the cell cycle inhibitor CIP1/WAF1 in lung alveolar epithelial cell growth arrest induced by glucocorticoids
8. 1 cyclins
9. Recent advances on cyclins, CDKs and CDK inhibitors
10. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase δ holoenzyme
11. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
12. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21(Cip1)
13. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57(KIP2) requires binding to proliferating cell nuclear antigen
14. p53-Independent expression of p21(Cip1) in muscle and other terminally differentiating cells
15. Translational control of p27(Kip1) accumulation during the cell cycle
16. p57(KIP2), A structurally distinct member of the p21(CIP1) Cdk inhibitor family, is a candidate tumor suppressor gene
17. Cloning of p57(KIP2), a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution
18. 1 checkpoint control
19. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
20. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)
21. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
22. Ablation of the CDK inhibitor p57(Kip2) results in increased apoptosis and delayed differentiation during mouse development
23. Altered cell differentiation in mice lacking p57(KIP2) indicates a role in Beckwith-Wiedemann syndrome
24. Selective maternal-allele loss in human lung cancers of the maternally expressed p57(KIP2) gene at 11p15.5
25. Ribonucleic acid expression of the clustered imprinted genes p57(KIP2), insulin-like growth factor II, and H19, in adrenal tumors and cultured adrenal cells
26. p15(Ink4B) Is a potential effector of TGF-β-induced cell cycle arrest
27. Transforming growth factor β induces the cyclindependent kinase inhibitor p21 through a p53-independent mechanism
28. Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1)
29. 3 leads to the induced differentiation of the myelomonocytic cell line U937
30. 3 in HL60 Cells
31. p27(Kip1): A key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line
32. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-α in hematopoietic cell lines
33. Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells
34. Glucocorticoid inhibition of fibroblast proliferation and regulation of the cyclin kinase inhibitor p21(Cip1)
35. Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21(waf1/cip1) promoter in rat hepatoma cells
36. Role of the CCAAT/enhancer binding protein-α transcription factor in the glucocorticoid stimulation of p21(waf1/cip1) gene promoter activity in growth arrested rat hepatoma cells
37. The effects of hydrocortisone on HeLa cell growth
38. Elevation of HeLa cell 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by glucocorticoids: Possible relationship to the cell cycle
39. 3 cell cycle
40. 1
41. 1 control in retinoblastoma gene-deficient cells, independent of CDK 4 activity
42. 1 progression
43. Glucocorticoid receptors
44. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes
45. Human Papillomavirus E6 and ET: Proteins which deregulate the cell cycle
46. Purification and analysis of CIP/KIP proteins
47. Growth suppression by p18, a p16(INK4/MT1) and p14(INK4B/MTS2)-related CDK6 inhibitor, correlates with wild-type pRb function
48. Tumour derived p16 alleles encoding proteins defective in cell cycle inhibition
49. Growth suppression by p16(INK4) requires functional retinoblastoma protein
50. Cyclin E-CDK2 is a regulator of p27(KIP1)
51. Phosphorylation dependent degradation of the cyclin-dependent kinase inhibitor p27(KIP1)
52. Cell cycle control of DNA replication
53. Cyclin/Cdk-dependent initiation of replication in a human cell-free system
54. p57(KIP2) Is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor β1
55. Repression of NF-κB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators
56. Characterization of the human p57(KIP2) gene: Alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational anlysis
57. Progesterone regulates transcription of the p21(waf1) cyclin dependent kinase inhibitor gene through Sp1 and CBP/p300
58. The inhibition of croton oil promoted mouse skin tumorigenesis by steroid hormones
59. Multiple effects of dexamethasone on protein synthesis and hyperplasia caused by a tumor promoter
60. Detection and analysis of proteins expressed from cloned genes
61. Cell synchronization as a basis for investigating control of proliferation in mammalian cells
62. Extraction, purification, and analysis of messenger RNA from eukaryotic cells
63. Preparation and analysis of RNA
64. Regulation of glucocorticoid receptor expression: Evidence for transcriptional and posttranslational mechanisms